1st Apr 2008 12:42
EiRx Therapeutics PLC01 April 2008 Financial Services Authority TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of Eirx Therapeutics Plcexisting shares to which voting rights are attached: 2. Reason for notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights An acquisition or disposal of financial instruments which may result in the acquisitionof shares already issued to which voting rights are attached An event changing the breakdown of voting rights X Other (please specify): 3. Full name of person(s) subject to the notification Barclays PLCobligation: 4. Full name of shareholder(s) (if different from 3): Barclays Stockbrokers Ltd 5. Date of transaction and date on which the threshold is 19-Mar-08crossed or reached: 6. Date on which issuer notified: 01-Apr-08 7. Threshold(s) that is/are crossed or reached: 13% to 11% 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to the Resulting situation after the triggering transactionshares Triggering transaction Number of Number of Number of Number of Voting % of voting rights Shares Voting Rights Shares RightsIf possible useISIN code Direct Indirect Direct Indirect GB00B0XQBS97 939,660,264 939,660,264 806,354,570 0 806,354,570 0.00 11.56 B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ conversion No. of voting rights Percentage of votinginstrument period/date that may be acquired rights (if the instrument exercised/converted) N/A N/A N/A N/A N/A Total (A+B)Number of voting rights Percentage of voting rights 806,354,570 11.56 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectivelyheld, if applicable:Barclays Stockbrokers Ltd Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease N/Ato hold: 12. Date on which proxy holder will cease to hold N/Avoting rights: 13. Additional information: N/A 14. Contact name: Geoff Smith 15. Contact telephone number 020 7116 2913 For notes on how to complete form TR-1 please see the FSA website. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Barclays